Aurinia shareholders reject say-on-pay, equity plan; four directors face conditional resignations

Aurinia Pharmaceuticals Inc.

CEO Peter Greenleaf and three other directors received less than majority support; conditional resignations submitted under Majority Voting Policy.
Say-on-pay vote failed: 30.8M for, 45.3M against, 0.5M abstain.
Equity Incentive Plan amendment not approved: 35.7M for, 40.5M against.
PricewaterhouseCoopers ratified as auditor with 85.6M for, 8.1M against.
Board will decide on the four directors' resignations within 90 days per policy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.